Security readout for executives and security teams
Plain-English summary
This CVE concerns older Android versions of Ascensia Contour NEXT ONE before January 15, 2019. Weak code obfuscation could let an attacker reverse engineer the app and extract sensitive data that may help disclose patients' medical information. The supplied sources do not provide a CVSS score or active exploitation evidence.
Executive priority
Prioritize if the organization supports patients or staff using this app on managed Android devices. The main business risk is medical privacy exposure from obsolete mobile software, but urgency is hard to quantify because public severity and exploitation evidence are incomplete.
Technical view
The vulnerability is described as weak obfuscation in the Android application, enabling reverse engineering of the codebase and extraction of sensitive data related to Ascensia platform users. The public bundle does not identify a CWE, detailed affected version range beyond pre-2019-01-15, or a vendor patch note.
Likely exposure
Exposure is likely limited to users or organizations still running the Ascensia Contour NEXT ONE Android app builds from before January 15, 2019, especially where patient diabetes data was used or synced through the platform.
Exploitation context
The sources describe a reverse-engineering risk, not a confirmed in-the-wild campaign. The CVE is not marked as CISA KEV in the supplied bundle. No exploit status, tooling, or attacker activity is cited.
Researcher notes
Evidence is sparse. The vulnerability hinges on weak obfuscation and reverse engineering leading to sensitive data extraction. Avoid assuming all Ascensia products are affected; the bundle names only Contour NEXT ONE for Android before 2019-01-15.
Mitigation direction
- Move users off Android app builds from before January 15, 2019.
- Confirm current Ascensia vendor guidance for supported app versions.
- Remove sideloaded or archived APK copies from managed devices.
- Use MDM controls to enforce approved app versions only.
- Treat related patient data exposure as privacy-sensitive for internal review.
Validation and detection
- Inventory Android devices for installed Contour NEXT ONE app versions.
- Confirm whether any installed build predates January 15, 2019.
- Check app source, update channel, and MDM compliance state.
- Determine whether affected users stored or synced medical data.
- Review Ascensia or app-store guidance for remediation status.
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CVE-2018-18977 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS and timeline data
No CVSS vectors or timeline events were available in the normalized CVE source material.
Source materials
- CVE List V5 sourceCVE List V5
- https://depthsecurity.com/blog/medical-exploitation-you-are-now-diabeticCVE reference · x_refsource_MISC
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.